Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
441
-
Total 13F shares, excl. options
-
57.1M
-
Shares change
-
+885K
-
Total reported value, excl. options
-
$8.9B
-
Value change
-
+$138M
-
Put/Call ratio
-
2.01
-
Number of buys
-
188
-
Number of sells
-
-191
-
Price
-
$156.01
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2022
499 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2022.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.1M shares
.
Largest 10 shareholders include BlackRock Inc. (6.51M shares), VANGUARD GROUP INC (5.76M shares), JPMORGAN CHASE & CO (3.38M shares), STATE STREET CORP (2.26M shares), WELLINGTON MANAGEMENT GROUP LLP (2.26M shares), LSV ASSET MANAGEMENT (1.73M shares), FMR LLC (1.6M shares), Polaris Capital Management, LLC (1.48M shares), RENAISSANCE TECHNOLOGIES LLC (1.43M shares), and SAMLYN CAPITAL, LLC (1.2M shares).
This table shows the top 441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.